-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 9, 2020, Jiangxi Pharmaceutical Price and Purchasing Service Center issued a notice on the public adjustment of the online procurement qualification of drugs such as Ramifeding.
In accordance with the Implementation Plan for the Central Procurement of Drugs in Public Hospitals in Jiangxi Province in 2015 and the Opinions of the General Office of the State Council on the Conduct of Consistent Evaluation of the Quality and Efficacy of Generic Drugs (State Office Issued No. 8 of 2016), the online procurement qualification of products that have been evaluated by consistency has been suspended for three other enterprises, and the procurement qualification shall be resumed after consistent evaluation.
Specifically, most of them are shortlisted varieties from the third batch of countries, such as celexib capsules, catoply tablets, polypyride tablets, chlorovine flat tablets, cycloproxacin tablets hydrochloric acid, kramycin tablets, hydrochloride bromine tablets ... The notice said that after the enterprise application and verification, is now part of the drug online procurement qualification adjustment for publicity, the public notice period until September 14, 2020, if there is any objection, please on September 14 before 17:00, the seal of the unit materials submitted to Jiangxi Province pharmaceutical procurement service platform "drug bargaining procurement system - bargaining procurement entrance - business processing - complaint processing."
attached: some of the drug online procurement qualification adjustment schedule